We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Health, Science, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.
The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.
Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database. Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.
Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Stuart Hughes as CEO of Nuage Therapeutics. “Coulter Partners has been an invaluable partner in this crucial appointment for Nuage Therapeutics,” said Vanessa Malier, chair of the board of directors of Nuage Therapeutics. “Their team demonstrated exceptional dedication and a truly collaborative spirit, working closely
Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Luis De Miguel Puig as chief data and technology officer of Clinical Partners. “Coulter Partners truly understood our requirements for a leader who could champion automation, self-service, and data-driven strategy,” said Barny Guthrie, CEO at Clinical Partners. “They delivered an impressive, diverse shortlist in under 30 days,
Life sciences recruiting specialist Coulter Partners has helped to recruit Amrik Basran as chief scientific officer of ExpressionEdits. “Amrik’s extensive experience in biologics development makes him an invaluable addition to ExpressionEdits,” said Kärt Tomberg, co-founder and CEO of ExpressionEdits. “His leadership will be key as we expand from platform innovation to therapeutic development, ensuring our technology
Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Jonathan Sadeh as executive vice president, chief medical officer and head of R&D at NYSE-traded Bausch Health Companies Inc. Antonietta Baffa, Lilyana Chukova, and Nona Footz led the assignment. “We are delighted to welcome Jonathan as our new head of research and development,” said Thomas J. Appio,
Coulter Partners successfully completed a search assignment for Melt&Marble and is pleased to announce the placement of Tue Hodal as its first Chief Technology Officer (CTO). Melt&Marble is a manufacturer of precision-fermented fats; the company has developed a proprietary technology designed to engineer yeast metabolism to produce tailored fats that meet specific functional and compositional requirements
Coulter Partners is proud of the successful placement of Dr. Stuart Hughes as Chief Executive Officer at Nuage Therapeutics S.L. (“Nuage”). Nuage is a biotech company focused on creating transformational precision therapies by targeting established oncogenic transcription factors. The Company has developed a set of tools that enables the reconstitution of intrinsically-disordered proteins (IDPs) in
Coulter Partners successfully completed a search assignment for Tozaro and is pleased to announce the placement of Dr. Jason Slingsby, MBA as Chief Executive Officer. Tozaro is a pioneering technology provider specializing in cell and gene therapy manufacturing. The company focuses on advancing its Smart Polymer technology to revolutionize downstream processing in this field. With
Coulter Partners recently partnered with MTIP and Coramaze Technologies (Coramaze) and is pleased to announce the placement of Rob ten Hoedt as Chair of Coramaze’s Board of Directors. Coramaze Technologies is a pre-commercial medical technology company, focused on developing a novel tricuspid valve repair system, called Tripair™, a minimally invasive solution for treating tricuspid regurgitation
Coulter Partners successfully completed a search assignment for Clinical Partners and is pleased to announce the placement of Luis De Miguel Puig as Chief Data and Technology Officer (CDTO). Clinical Partners is a UK leading provider of mental health services which works both privately and with the NHS to help people and families experiencing mental
News
Coulter Partners attends Bio€quity Europe in Bruges, Belgium
Coulter Partners attends Danish Biotech Spring Gala
Top hires for VC & PE portfolio companies Q1-2025
Evolution Italy: Life Science leaders gather for insightful discussions
Coulter Partners at BioCapital Europe 2025: Innovation and optimism reign
BioInnovation Institute Breakfast Seminar Health Tech Ecosystem – Copenhagen
BIA Gala Dinner 2025
Top hires for VC & PE portfolio companies Q4-2024
Top global hires for large-cap, mid-cap and public companies H2-2024
Coulter Partners attends AESC Global Conference: Inspire. Innovate. Impact.
Coulter Partners hosts inaugural annual partners meeting
Top hires for VC & PE portfolio companies Q3-2024
Packed house for Coulter Partners’ latest HealthTech Ecosystem breakfast
Coulter Partners runs Vitality 10K to raise money for Kith & Kids charity
Top hires for VC & PE portfolio companies Q2-2024
Top global hires for large-cap, mid-cap and public companies H1-2024
D, E & I: VIEWS FROM LEADERSHIP SERIES – Ankit Mahadevia, MD, Founder and Chair of Spero Therapeutics, and author of Quiet Leader, Loud Results
Top hires for VC & PE portfolio companies Q1-2024
D, E & I: VIEWS FROM LEADERSHIP SERIES – Lene Gerlach, Founder and Chair of Women in Life Science Denmark (WiLD), and Partner at Eir Ventures
D, E & I: VIEWS FROM LEADERSHIP SERIES – Yael Gruenbaum-Cohen, Partner at aMoon and Founder of WE@HealthTech
Top hires for VC & PE portfolio companies Q4-2023
Top global hires for large-cap, mid-cap and public companies H2-2023
Top hires for VC & PE portfolio companies Q3-2023
Top hires for VC & PE portfolio companies Q2-2023
Top global hires for large-cap, mid-cap and public companies H1-2023
Top hires for VC & PE portfolio companies Q1-2023
D, E & I: Views From Leadership Series – Charlotte Valeur, Founder of Institute Of Neurodiversity, ION
Top hires for VC & PE portfolio companies Q4-2022
Top global hires for large-cap, mid-cap and public companies H2-2022
Diversity, Equity, & Inclusion: Views From Leadership Series- Quita Highsmith, Vice President and Chief Diversity Officer at Genentech
Diversity, Equity & Inclusion: Views from Leadership-Tomoko Adachi
Diversity, Equity & Inclusion: Views from Leadership-Corinne Le Goff